Skip to main content

Invitrogen Completes Molecular Probes Acquisition

NEW YORK, Aug. 22 (GenomeWeb News) - Invitrogen announced today that it had completed its acquisition of Molecular Probes.

 

"As a leader in life sciences consumables, we believe that Invitrogen's worldwide sales, marketing and distribution capabilities will accelerate the penetration of Molecular Probes' core technologies into new markets," said Invitrogen CEO Greg Lucier in a statement that also reaffirmed the company's financial guidance for 2003.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.